Ericsson Anders, Frenckner Björn, Broman L Mikael
Prehosp Emerg Care. 2017 Jul-Aug;21(4):448-455. doi: 10.1080/10903127.2017.1282561. Epub 2017 Feb 6.
Extracorporeal membrane oxygenation (ECMO) may be a lifesaving rescue therapy in refractory, severe respiratory, and/or circulatory failure. To provide the best cost efficiency to the population served and patient outcome, ECMO therapy should be provided by specialized high volume ECMO centers. This requires dedicated transport teams to organize and perform these complex transports. Concerning adverse events and complications during these transfers, only a minimal amount of data has been published.
To shed light on this matter, all medical transport records from transports on ECMO between January 2010 and June 2016 were analyzed. The data was classified in constituent groups and categorized to risk groups.
During the study period, 536 transports on ECMO were performed. The transport records could be identified in 514 of these cases (95.9%). In 163 (31.7%) transports 206 adverse events occurred. In 34 transports two or more adverse events passed on the same trip. No deaths occurred during transport. Sixty-five percent (134) of the complications were Patient related; the most prominent was loss of tidal volume with or without fluid flooding of the lung (n = 57, 43%). Lack of control of equipment was the most common Staff related flaw. Causes due to Equipment/technical (n = 30) could be traced to 14.6% of the events. Vehicle/transportation related complications were reported from 26 transfers, a sub-group in which 50% of the reports concerned malfunction of Ambulance utility/electrical, or Wrong ambulance size at hospital or airport.
If transporting on ECMO high-risk or sudden threat-of-life situations are inevitable and have to be dealt with immediately, sometimes within seconds. A well-trained staff and an experienced high-volume organization are recommended. Key words: extra corporeal membrane oxygenation; ECMO, transport; adverse event; complication.
体外膜肺氧合(ECMO)可能是治疗难治性严重呼吸和/或循环衰竭的一种挽救生命的治疗方法。为了给所服务的人群提供最佳成本效益和患者预后,ECMO治疗应由专业的高容量ECMO中心提供。这需要专门的转运团队来组织和实施这些复杂的转运。关于这些转运过程中的不良事件和并发症,仅有少量数据发表。
为了阐明这一问题,对2010年1月至2016年6月期间ECMO转运的所有医疗转运记录进行了分析。数据被分类为组成组并归类为风险组。
在研究期间,共进行了536次ECMO转运。其中514例(95.9%)的转运记录可被识别。在163次(31.7%)转运中发生了206起不良事件。在34次转运中,同一次行程发生了两起或更多不良事件。转运过程中无死亡发生。65%(134例)的并发症与患者相关;最突出的是潮气量丧失,伴有或不伴有肺内液体充盈(n = 57,43%)。设备控制不足是最常见的与工作人员相关的缺陷。设备/技术原因(n = 30)导致的事件占14.6%。26次转运报告了与车辆/运输相关的并发症,其中50%的报告涉及救护车设施/电气故障,或医院或机场救护车尺寸错误。
如果进行ECMO转运,高风险或危及生命的突发情况不可避免,必须立即处理,有时要在数秒内处理。建议配备训练有素的工作人员和经验丰富的高容量组织。关键词:体外膜肺氧合;ECMO,转运;不良事件;并发症。